Full-Time

Administrator

Posted on 9/12/2025

Deadline 9/12/26
BrightSpring Health Services

BrightSpring Health Services

10,001+ employees

Home-based and community health services, pharmacy

No salary listed

Bristol, VA, USA

In Person

Category
Administrative & Executive Assistance (1)
Requirements
  • A person who is a licensed physician, or
  • Is a registered nurse, or
  • Has training and experience in health services administration and at least two years of supervisory or administrative experience in Hospice or related health program
  • Demonstrated ability in or application of organizational/communication skills
  • Ability to deal effectively with high levels of stress
  • Ability to enlist the cooperation of many people in furthering a program
Responsibilities
  • The Administrator ensures quality and safe delivery of Hospice services; coordinates services that reflect Hospice's philosophy and standards of care; and plans, develops, implements and evaluates Hospice services, programs and activities
  • Organizes and directs Hospice’s ongoing liaison among the Governing Body and staff
  • Employees qualified personnel and ensures adequate staff education and evaluations
  • Ensures the accuracy of public information materials and activities
  • Implements an effective budgeting and accounting system; assures accuracy for billing procedures
  • Shares copies of philosophy with all employees
  • Consistently follows Hospice policies and procedures to set an example for employees
  • Negotiates required contracts and ultimately oversees contract provisions
  • Assesses employees on an ongoing basis to ascertain their understanding of policies and procedures
  • Assists employees to support policies and achieve necessary changes
  • Uniformly enforces policies and procedures
  • Maintains two way communication with employees and fair administration of personnel policies
  • Documents employee problems in personnel files
  • Disciplines employees as necessary
  • Directs Hospice's ongoing functions
  • Monitors budget hours and does not exceed allowance each year
  • Monitors equipment abuse and takes steps to keep it to a minimum
  • Evaluates effectiveness and efficiency of Hospice
  • Uses statistical data to determine quality and quantity of services
  • Maintains compliance with applicable federal, state and local rules and regulations and accreditation standards
  • Supervises all business affairs
  • Develops, implements and evaluates financial policies and procedures and records
  • Develops, implements and evaluates budget plan and cost control policies and procedures
  • Develops and implements salary program within approved policies and procedures
  • Participates in personal professional growth and development
  • Plans and directs operations to ensure the provision of adequate and appropriate care and services
  • Fiscal planning, budgeting and management
  • Recruits employees and retains qualified personnel to maintain appropriate staffing levels
  • Establishes and maintains effective channels of communication
  • Ensures personnel have current clinical information and material about current practices
  • Evaluates services and programs
  • Ensures staff development including orientation, in service education and continuing education
  • Coordinates with other program areas and management as appropriate
  • Maintains current knowledge of local trends and issues
  • Ensures that appropriate service policies are developed and implemented
  • Directs staff in performance of their duties including admission, discharge and provision of service to patients
  • Assures appropriate staff supervision during all operating hours
  • Ensures the accuracy of public information materials and activities
  • Establishes and oversees the Quality Assessments/Performance Improvement Program
  • Appoints a similarly qualified alternate to be available at all times during operating hours in the absence of the Administrator
BrightSpring Health Services

BrightSpring Health Services

View

BrightSpring Health Services provides home and community-based health care through two main operations: Pharmacy and Provider. In Pharmacy, it offers services for patients with complex and chronic conditions, including specialty, infusion, and community pharmacy solutions. In Provider, it delivers home health, behavioral health, hospice care, and services for intellectual and developmental disabilities. The company uses an integrated care model that connects pharmacy services with in-home care across its network to support patients, families, and managed care organizations. Revenue comes from reimbursed services paid by Medicare, Medicaid, and private insurers. Its goal is to coordinate ongoing, in-home and community-based care across a continuum—from pharmacy support to direct care—ensuring coordinated, patient-centered services for individuals with complex or chronic needs.

Company Size

10,001+

Company Stage

Post IPO Equity

Headquarters

Louisville, Kentucky

Founded

1974

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $3.61B, up 26%, raising full-year guidance to $14.98B.
  • Amedisys and LHC acquisitions add 107 locations, contributing $30M EBITDA in 2026.
  • Sevita sale yields $811M cash for debt reduction and $2B M&A through 2028.

What critics are saying

  • Money Message ransomware stole 2M records including SSNs in March 2023 breach.
  • DOJ fined ResCare in October 2019 for fake Medicaid revaluations from 2009-2014.
  • Pomerantz investigates securities fraud by BrightSpring officers as of 2026.

What makes BrightSpring Health Services unique

  • BrightSpring integrates specialty pharmacy with home health for complex chronic care patients.
  • PharMerica dispenses 40 million prescriptions annually to 4 million patients.
  • Provider services target intellectual disabilities via home-based behavioral health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Company News

Yahoo Finance
Apr 10th, 2026
BrightSpring Health shares jump 5.2% on 15-20% EBITDA growth targets and AI efficiency plans

BrightSpring Health Services announced the resignation of Robert Barnes as President of ResCare Community Living on 30 March 2026, stating it was not due to any disagreement over operations or policies. The company's shares rose 5.2% following upbeat analyst reports from its investor day. Management unveiled ambitious long-term organic EBITDA growth targets of 15% to 20% annually through 2028, alongside AI-driven efficiency plans for its home and community-based care platform. The narrative projects $16.8 billion in revenue and $361.8 million in earnings by 2028, requiring 10.1% yearly revenue growth. Investors remain focused on whether BrightSpring can balance acquisition-driven expansion and technology investment whilst managing its substantial debt load and regulatory exposure.

Yahoo Finance
Mar 30th, 2026
BrightSpring Health Services stock surges 43% in 6 months, but low ROIC raises concerns

BrightSpring Health Services has seen its stock price surge 43.1% over the past six months to $42.32 per share, driven by strong quarterly results. The healthcare services company, founded in 1974, offers home health care, hospice, neuro-rehabilitation and pharmacy services. BrightSpring's revenue grew at an 18.3% compound annual growth rate over the past five years, outpacing the healthcare sector average. Analysts forecast 15% revenue growth over the next 12 months, though this represents a deceleration from its recent 20.9% annual rate. However, the company's five-year average return on invested capital of 4.9% falls below the typical cost of capital for healthcare firms, suggesting historically mediocre capital efficiency. The stock currently trades at 27.7× forward price-to-earnings ratio.

Yahoo Finance
Mar 25th, 2026
BrightSpring trades at 24.5x forward P/E despite $600M revenue headwinds

BrightSpring Health Services has raised questions about its valuation after trading at 24.5 times forward earnings following strong 2025 performance. The company reported fourth-quarter revenue of $3.55 billion, up 29.3% year-over-year, with adjusted EBITDA rising 40.7% to $184 million. For 2026, management guided revenue between $14.45 billion and $15 billion, representing 11.9% to 16.2% growth, whilst adjusted EBITDA is expected to grow faster at 23% to 28%, indicating margin expansion. However, the company faces approximately $600 million in revenue headwinds from Inflation Reduction Act impacts and brand-to-generic conversions. The valuation hinges on whether BrightSpring can deliver sequential profitability improvements throughout the year despite policy and product-mix pressures affecting headline revenue growth.

Yahoo Finance
Mar 24th, 2026
BrightSpring tops Q4 senior health earnings as Chemed's $639M revenue disappoints

BrightSpring Health Services led senior health stocks in Q4 earnings, reporting revenues of $3.55 billion, up 16.3% year on year and beating analyst expectations by 5%. The company delivered strong full-year EBITDA guidance. In contrast, Chemed posted the weakest performance, with revenues of $639.3 million falling 3% short of expectations. The company missed both revenue and full-year EPS guidance estimates, sending shares down 19.2% to $377.07. The seven senior health, home health and hospice stocks tracked reported slower Q4 results overall, with revenues beating consensus estimates by just 1.1%. Share prices have declined an average of 9.6% since earnings releases. The sector faces headwinds from labour shortages and wage inflation whilst benefiting from an ageing population and growing preference for in-home care.

Yahoo Finance
Mar 19th, 2026
BrightSpring projects sub-2x leverage in 2026, unveils $2B M&A firepower and integrated care strategy

BrightSpring Health Services outlined its growth strategy at an investor day, highlighting a shift towards core home-and-community clinical services. The company's planned community-living divestiture will close soon to boost cash flow and support integrated care initiatives. BrightSpring reported significant deleveraging from approximately 4.5x post-IPO to 2.99x (2.6x pro forma), with leverage expected to fall below 2x in 2026. The company reiterated 2026 guidance of $14.45–$15.0 billion revenue and $760–$790 million adjusted EBITDA, whilst targeting 15–20% organic adjusted EBITDA compound annual growth for 2026–2028. The healthcare services provider has at least $2 billion available for acquisitions through 2028. Its operations include dispensing over 40 million prescriptions annually through PharMerica, serving more than 4 million patients, with recent branch integrations expected to add approximately $30 million of EBITDA.

INACTIVE